m6A modification: recent advances, anticancer targeted drug discovery and beyond

m6A modification: recent advances, anticancer targeted drug discovery and beyond

Abstract Abnormal N6-methyladenosine (m6A) modification is closely associated with the occurrence, development, progression and prognosis of cancer, and aberrant m6A regulators have been identified as novel anticancer drug targets. Both traditional medicine-related approaches and modern drug discove...

Full description

Bibliographic Details
Main Authors: Li-Juan Deng, Wei-Qing Deng, Shu-Ran Fan, Min-Feng Chen, Ming Qi, Wen-Yu Lyu, Qi Qi, Amit K. Tiwari, Jia-Xu Chen, Dong-Mei Zhang, Zhe-Sheng Chen
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Molecular Cancer
Subjects:
m6A
Cancer
Modulators
Drug discovery
Natural product
Chemosynthesis
Online Access:https://doi.org/10.1186/s12943-022-01510-2

Internet

https://doi.org/10.1186/s12943-022-01510-2

Similar Items